We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,486 results
  1. Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors

    Background

    Pituitary neuroendocrine tumors (PitNETs) are one of the most common types of intracranial tumors. Currently, the cellular characteristics...

    Nan Yan, Weiyan **e, ... Chuzhong Li in Genome Medicine
    Article Open access 02 January 2024
  2. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage–tumor interaction axes among different lineages of pituitary neuroendocrine tumors

    Background

    Pituitary neuroendocrine tumors (PitNETs) are common gland neoplasms demonstrating distinctive transcription factors. Although the role of...

    Shaojian Lin, Yuting Dai, ... Zhe Bao Wu in Genome Medicine
    Article Open access 24 April 2024
  3. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis

    Pituitary neuroendocrine tumors (PitNETs) are common, generally benign tumors with complex clinical characteristics related to hormone hypersecretion...

    Abdellah Tebani, Jelena Jotanovic, ... Fredrik Pontén in Acta Neuropathologica Communications
    Article Open access 10 November 2021
  4. Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors

    We aimed to identify the druggable cell-intrinsic vulnerabilities and target-based drug therapies for PitNETs using the high-throughput drug...

    Yijun Cheng, Yuting Dai, ... Zhe Bao Wu in Acta Neuropathologica Communications
    Article Open access 18 April 2024
  5. Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors

    Human growth hormone (GH) is the indispensable hormone for the maintenance of normal physiological functions of the human body, including the growth,...

    Lamei Yang, Chunling Li, ... **anquan Zhan in EPMA Journal
    Article 27 June 2023
  6. Benign and Malignant Tumors of the Pituitary Gland

    Pituitary glandPituitary gland tumors represent approximately 10–15% of all brain tumorsBrain tumor and the most common neoplasmsNeoplasm of the...
    Luigi Albano, Marco Losa, ... Pietro Mortini in Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2
    Chapter 2023
  7. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine

    Nonfuctional pituitary neuroendocrine tumor (NF-PitNET) is highly heterogeneous and generally considered a common intracranial tumor. A series of...

    Siqi Wen, Chunling Li, **anquan Zhan in EPMA Journal
    Article 17 February 2022
  8. Missing pieces of the pituitary puzzle: participation of extra-adenohypophyseal placode-lineage cells in the adult pituitary gland

    The pituitary gland is a major endocrine tissue composing of two distinct entities, the adenohypophysis (anterior pituitary, cranial placode origin)...

    Yukio Kato, Saishu Yoshida, Takako Kato in Cell and Tissue Research
    Article 31 August 2023
  9. Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies

    Pituitary neuroendocrine tumors (PitNETs) are the second most common type of intracranial neoplasia. Since their manifestation usually causes hormone...

    Busra Aydin, Aysegul Caliskan, Kazim Yalcin Arga in EPMA Journal
    Article 26 June 2021
  10. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis

    The purpose of this study was to analyze the impact of copy number variations (CNV) on sporadic pituitary neuroendocrine tumors (PitNETs) prognosis,...

    Hélène Lasolle, Mad-Hélénie Elsensohn, ... Gérald Raverot in Acta Neuropathologica Communications
    Article Open access 10 November 2020
  11. Central Nervous System Tumors

    The central nervous system (CNS) is the part of the nervous system comprising the brain and the spinal cord. CNS tumors are a heterogeneous group of...
    Deep Chakrabarti, Jasmeet Singh Tuteja, Madan Lal Brahma Bhatt in Molecular Biomarkers for Cancer Diagnosis and Therapy
    Chapter 2024
  12. Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours

    Non-functioning pituitary tumours (NF-PitNETs) are common intracranial benign neoplasms that can exhibit aggressive behaviour by invading...

    Ashutosh Rai, Soujanya D. Yelamanchi, ... Carles Gaston-Massuet in Acta Neuropathologica Communications
    Article Open access 16 September 2022
  13. A History of Immune and Neuroendocrine System Interactions

    The purpose of this chapter is to provide a twentieth century history of neuroendocrine and immune systems and the interactions of their components....
    Chapter 2023
  14. The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages

    Background

    Pituitary adenomas (PA) are the second most common intracranial tumors and are classified according to hormone they produce, and the...

    Keiko Taniguchi-Ponciano, Lesly A. Portocarrero-Ortiz, ... Moisés Mercado in BMC Medical Genomics
    Article Open access 08 March 2022
  15. The Epidemiology of Brain and Spinal Cord Tumors

    CNS tumors are a diverse group of neoplasmsNeoplasm that emerge from a variety of different CNSCentral Nervous System (CNS) cell types. These tumors...
    Parnian Shobeiri, Homa Seyedmirzaei, ... Sara Hanaei in Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1
    Chapter 2023
  16. Energy Balance and Neuroendocrine-Immune Regulation in Chronic Inflammatory and Neoplastic Diseases: An Evolutionary Perspective

    The central nervous and immune systems are often in competition for energy substrates. After infection or injury, energy expenditure typically...
    Jan Pieter Konsman, Rainer H. Straub in Neuroendocrine-Immune System Interactions
    Chapter 2023
  17. Germline whole genome sequencing in adults with multiple primary tumors

    Multiple primary tumors (MPTs) are a harbinger of hereditary cancer syndromes. Affected individuals often fit genetic testing criteria for a number...

    Yiming Wang, Qiliang Ding, ... Raymond H. Kim in Familial Cancer
    Article 22 July 2023
  18. Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

    Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on increased androgen receptor (AR) signaling. Therefore,...

    Lina Merkens, Verena Sailer, ... Gunhild von Amsberg in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 February 2022
  19. Glioneuronal and Neuronal Tumors of the Central Nervous System

    Glioneuronal and neuronal tumorsGlioneuronal and neuronal tumors (GNT) (GNTs) are rare neoplasmsNeoplasm composed of neural and glial elements...
    Matteo Martinoni, Viscardo Paolo Fabbri, ... Caterina Giannini in Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2
    Chapter 2023
  20. Brain Control over Pituitary Gland Hormones

    Endocrine organs release their products, hormones, into peripheral blood to travel great distances to exert their biological effects. The brain is...
    Arturo E. Gonzalez-Iglesias, Marc E. Freeman in Neuroscience in the 21st Century
    Reference work entry 2022
Did you find what you were looking for? Share feedback.